Skip to main content
Bo Huang, MD, Ophthalmology, Jackson, MS

Bo Huang MD

Cataract Related, Cornea & External Disease, Retinal Disease


Associate Professor, Ophthalmology, University of Mississippi School of Medicine

Join to View Full Profile
  • 2500 N State StSte B319Jackson, MS 39216

  • Phone+1 601-984-5020

  • Fax+1 601-815-3773

Dr. Huang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of South Florida Morsani
    University of South Florida MorsaniResidency, Ophthalmology, 1999 - 2002
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonInternship, Transitional Year, 1998 - 1999
  • Medical College of Nanchang University
    Medical College of Nanchang UniversityClass of 1983

Certifications & Licensure

  • MS State Medical License
    MS State Medical License 2003 - 2025
  • FL State Medical License
    FL State Medical License 2001 - 2005
  • IL State Medical License
    IL State Medical License 2002 - 2005
  • MO State Medical License
    MO State Medical License 2002 - 2004
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Fellow (FAAO) American Academy of Ophthalmology

Publications & Presentations

PubMed

Press Mentions

  • ORIGINAL RESEARCH Genome-Wide 5-Hydroxymethylcytosine Profiling Analysis Identifies MAP7D1 as A Novel Regulator of Lymph Node Metastasis in Breast Cancer
    ORIGINAL RESEARCH Genome-Wide 5-Hydroxymethylcytosine Profiling Analysis Identifies MAP7D1 as A Novel Regulator of Lymph Node Metastasis in Breast CancerMarch 11th, 2021
  • Integrated Vaccination and Physical Distancing Interventions to Prevent Future COVID-19 Waves in Chinese Cities
    Integrated Vaccination and Physical Distancing Interventions to Prevent Future COVID-19 Waves in Chinese CitiesFebruary 18th, 2021
  • Boosting Anti-PD-1 Therapy with Metformin-Loaded Macrophage-Derived Microparticles
    Boosting Anti-PD-1 Therapy with Metformin-Loaded Macrophage-Derived MicroparticlesJanuary 19th, 2021
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: